Idris Oncology BV

Idris Oncology BV is a medical device company based in Leiden Bio Science Park, Netherlands, founded in 2016. The company focuses on the research, development, and commercialization of innovative cancer diagnostic technologies, particularly in rare biomarker enrichment. Idris Oncology is the sole inventor and owner of several patents related to its proprietary technologies. The company develops flow biopsy tools that capture tumor cells directly from a patient's bloodstream using specialized coated wires. This method allows for the accumulation of circulating tumor cells over time, providing more accurate samples compared to traditional liquid biopsies. The technology aims to enhance early cancer detection by capturing circulating tumor DNA and cells, facilitating precise diagnostics and monitoring. Idris Oncology has completed successful animal trials and is preparing for clinical trials, actively seeking capital and partnerships for future projects. Idris Oncology serves healthcare providers, cancer diagnostic centers, research institutions, and biotech companies, offering less invasive and more accurate biopsy alternatives. The company is recognized for its contributions to biomedical research and is part of the Codex4SME consortium, which allows it to work with human tissue samples.

• Employees 6
• Founded 2016